CAR T-cell therapy is a new form of treatment for patients diagnosed with acute lymphoblastic leukemia that has shown promising results. Learn who is a candidate for CAR T-cell therapy, the steps involved and potential side effects and outcomes/
This is a recording of the webinar, Being a Caregiver: CAR T-Cell Therapy, that aired on February 1, 2023.
CAR T-cell therapy is a new approach to treating certain types of lymphoma, multiple myeloma and acute lymphoblastic leukemia that have not responded to two prior types of treatment.
CAR T-cell therapy is a promising treatment for patients who have relapsed (the disease came back after treatment) or refractory (the disease did not respond to intial thereapy) non-Hodgkin lymphoma.
CAR T-cell and other new drugs are expanding treatment options for patients with myeloma.
Learn how new cellular therapies, like CAR T-Cell therapy, can help patients with certain blood disorders.
¿Qué es la terapia con el receptor de antígeno quimérico (CAR-T)? ¿Quién es candidato para la terapia CAR-T?
Learn how CAR T therapy works to fight cancer, who is a candidate for CAR T therapy, the side effects and whether it can cure or prolong life.
The family caregiver plays a vital role in the patient’s recovery.
Learn More
Learn how to help your child through the transplant experience.
Learn More
GVHD is a common problem after a transplant using donor cells.
Learn More